Author Question: During coagulation a circulating substance creates a meshwork to reinforce the blood clot and ... (Read 87 times)

Pineappleeh

  • Hero Member
  • *****
  • Posts: 585
During coagulation a circulating substance creates a meshwork to reinforce the blood clot and stabilize it. What is this substance called?
 
  A) Fibrin
  B) Platelets
  C) Antibodies
  D) Rh antigen

Question 2

After several cycles of lab testing on test animals, a medication can enter clinical trials for evaluation in humans. In phase one clinical trial testing:
 
  A) the trial is expanded to include a large sample size, usually in the thousands of individuals, and establish the overall safety and effectiveness of the drug.
  B) the medication is compared to other medications on the market.
  C) consists of the drug being tested on a small number (usually 300 or less) of people with the illness or condition the drug is designed to treat.
  D) researchers attempt to determine the safe dose and how the medication is both absorbed and eliminated from the body.



parshano

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

A

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

parshano

  • Sr. Member
  • ****
  • Posts: 333

 

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

For a complete list of videos, visit our video library